Chairman Ma Jianrong increased his holdings in SHENZHOU INTL (02313) by 1.05 million shares, with a price of 47.68 Hong Kong dollars per share.

19:02 02/04/2026

On April 1st, Chairman Ma Jianrong increased his holdings of Shenzhou International (02313) by 1.05 million shares, at a price of 47.68 Hong Kong dollars per share, with a total amount of approximately 50.64 million Hong Kong dollars.

According to the latest information from the Hong Kong Stock Exchange, on April 1, Chairman Ma Jianrong increased his holdings of SHENZHOU INTL (02313) by 1.05 million shares at a price of 47.68 Hong Kong dollars per share, with a total amount of approximately 50.064 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 639 million shares, with a new shareholding ratio of 42.52%. This transaction involves other related parties: SPLENDID STEED INVESTMENTS LIMITED.

China Securities Co., Ltd. reviews the A-share market in the first quarter of 2026: This bull market is more forward-looking in terms of regulation and will take timely measures to address overheated trading.

Jiangsu Aidea Pharmaceutical Group (688488.SH): A clinical trial for a new type 1 drug ACC085 injection in the field of HIV treatment will be conducted.

Subsidiary company of Shenzhen Nanshan Power (000037.SZ) plans to invest in the construction of a 300MW/600MWh independent energy storage power station in the Cuiheng New Area of Zhongshan City (Phases Two and Three) project.

Jiangsu Aidea Pharmaceutical Group (688488.SH): A clinical trial for a new type 1 drug ACC085 injection in the field of HIV treatment will be conducted.